Diabetes

Featured Article
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says…
Advanced DNA-Based Medicine May Offer Lasting Pain Relief in Diabetic Peripheral Neuropathy
Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd, discuss a non-viral plasmid DNA-based medicine that, when injected into muscles, stimulates…

Newsfeed

Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
Advanced DNA-Based Medicine May Offer Lasting Pain Relief in Diabetic Peripheral Neuropathy
Mental Illness Affects Almost a Third of Active-Duty Service Veterans With Diabetes
VA Diabetes Risk Cohort Provides Largest Pool of US Adults Without Diabetes at Baseline
Continuous Diffusion of Oxygen Therapy Cost-Effective for Advanced Diabetic Foot Ulcers
Study Finds Higher 5-Year Costs With Semaglutide Instead of Sitagliptin for Type 2 Diabetes
Diabetes Increases Readmission Risk After Elective Total Joint Arthroplasty
View More

Insights

Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh, consultant…
Advanced DNA-Based Medicine May Offer Lasting Pain Relief in Diabetic Peripheral Neuropathy
Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd, discuss a non-viral plasmid DNA-based medicine that, when injected into muscles, stimulates the synthesis of twin proteins that are, in fact,…
Implementing Patient Education Strategies to Help Patients in Reducing or Preventing the Incidence of Prediabetes, Type 2 Diabetes
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
View More

Interactive Features

Examining a Treatment Option for Veterans With Diabetes, Foot Ulcers
Bob Maguire, BioLab Sciences, and Charles Pollak, Red One Medical, discuss their recent partnership and highlight a treatment option for veterans with diabetic foot ulcers, which impacts roughly 75,000 veterans.
How Hepatitis C Treatment Success Relates to Insulin Resistance
Does hepatitis C treatment success improve insulin resistance in patients with diabetes?
View More
Back to Top